Exceptional entrepreneurs. Bold growth stories.

We’re a Belgium-based private equity firm led by senior dealmakers focused on growth investments in mid-sized companies in Belgium and beyond. With combined €325m under management, PE Group and its success fund PE Capital Group actively supports outstanding growth companies.

We seek businesses that have demonstrate a strong position and reached profitability with an unique expansion plan for internationalisation or targeted ‘buy & build’ strategy. Our investment approach is hands-on and involve. We don’t just bring in just capital but strategic & financial guidance to help companies navigate growth.

Entrepreneurial approach

We approach each deal with a hands-on, management-supportive, committed and entrepreneurial investment approach as (co)-lead investor, blending an entrepreneurial approach with a disciplined professional private equity methodology

Investment consortium group with €325M AUM

PE Group and it successfor fund PE Capital Group form part of a larger €325M investment group controlled by the Van Rompuy family, one of the most prominent family offices in the pharma industry (Docpharma, Uteron Pharma, Alter Pharma,Hyloris, etc.)

Hidden industry gems

We’re convinced that exceptional entrepreneurs are what make the difference. We’re sector-agnostic, and instead specialise in finding entrepreneurial teams and companies that are local champions within their industry, driven by an ambitious growth story.

Track record 20+ years

Solid proven track record with double digit returns for investors, ranging from industry-reference sales to large IPOs in Benelux. In the last 17 years, PE Group has made 10 investments and realised 4 exits with a long-term IRR to date of nearly 20%

Management Team

Senior dealmakers that leverage together 85+ years of experience in private equity experience with an outstanding track record of successful exits, IPO and M&A in local and international context.

For over 20+ years, Stefan and Stijn have been close partners joint dealmakers recognised within private equity industry and navigating Euronext public companies

Stefan Yee

Combines +35 years of experience in Private Equity, Corporate Finance, M&A, Corporate Law and Governance in private and public companies.

Currently chairman of 2 Euronext-listed companies. Strong and consistent exit and IPO track record

Stijn Van Rompuy

Over 20 years of experience as CEO and serial entrepreneur in the pharma industry with Hyloris; Docpharma, Uteron Pharma, Alter Pharma, ING, etc.

Cornerstone investor in both PE Group and PE Capital Group with strong track record as overall dealmaker